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Abstract
Background: The mechanisms that regulate the activity of the nonreceptor tyrosine kinase Ack1 (activated
Cdc42-associated kinase) are poorly understood. The amino-terminal region of Ack1 is predicted to contain a sterile
alpha motif (SAM) domain. SAM domains share a common fold and mediate protein-protein interactions in a wide
variety of proteins. Here, we addressed the importance of the Ack1 SAM domain in kinase activity.
Results: We used immunofluorescence and Western blotting to show that Ack1 deletion mutants lacking the
N-terminus displayed significantly reduced autophosphorylation in cells. A minimal construct comprising the
N-terminus and kinase domain (NKD) was autophosphorylated, while the kinase domain alone (KD) was not. When
expressed in mammalian cells, NKD localized to the plasma membrane, while KD showed a more diffuse cytosolic
localization. Co-immunoprecipitation experiments showed a stronger interaction between full length Ack1 and
NKD than between full length Ack1 and KD, indicating that the N-terminus was important for Ack1 dimerization.
Increasing the local concentration of purified Ack1 kinase domain at the surface of lipid vesicles stimulated
autophosphorylation and catalytic activity, consistent with a requirement for dimerization and trans-
phosphorylation for activity.
Conclusions: Collectively, the data suggest that the N-terminus of Ack1 promotes membrane localization and
dimerization to allow for autophosphorylation.
Background
Ack1 is a 120 kDa non-receptor tyrosine kinase (NRTK)
with the domain arrangement shown in Figure 1A.
From N- to C-terminus, Ack1 contains a sterile alpha
motif (SAM) domain [1], a kinase domain, an SH3
domain, a Cdc42-binding domain (CRIB), a clathrin-
binding motif [2], a region homologous to Mig6 [3], and
a ubiquitin binding domain [4]. The C-terminal portion
of Ack1 also contains several proline-rich sequences
that serve as protein-protein interaction motifs [5-8].
Members of the Ack family include human Ack1/Tnk2
[9], Tnk1/Kos1 in human and mouse [10,11], bovine
Ack2 [12], DACK and DPR2 in Drosophila melanogaster
[13] and Ark-1 in Caenorhabditis elegans [14]. The iso-
forms share the overall domain arrangement of Ack1
(i.e. a kinase domain followed by an SH3 domain and
Pro-rich sequences), but differ in some details. For
instance, Ack2 has a shorter N-terminal region and a
shorter C-terminal portion [12]. The isoforms Tnk1,
Kos1 and DACK do not have a CRIB domain and are
shorter than Ack1 [10,13,15].
Several proteins have been shown to interact with
Ack1. GTP-bound Cdc42 binds to the CRIB domain
and activates Ack1 [9]. Ligands for the proline-rich
region of Ack1 include the SH3 domains of Hck [8],
Grb2 [6], SNX9 [6,7], and the WW domain of the E3
ubiquitin ligase Nedd4-2 [5]. Upon activation by Cdc42,
Ack1 phosphorylates the guanine exchange factor Dbl
[16,17] and the adapter protein p130Cas [18]. Although
the physiological roles of Ack1 are still unclear, it has
been implicated in several signaling pathways. Ack1 is
phosphorylated and activated in response to multiple
growth factors [1,6] and integrin-mediated signals
[18,19]. Ack1 participates in a signaling complex with
EGFR [4]. In addition, due to its interaction with pro-
teins such as ubiquitin [4], clathrin heavy chain [2,20]
and the sorting nexin SH3PX1 [21], Ack1 is thought to
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reproduction in any medium, provided the original work is properly cited.Figure 1 The N-terminus of Ack1 is required for autophosphorylation in cells. A, constructs used in this study: WT, full length Ack1
(accession # Q07912); ΔNt, deletion of the N-terminal 110 amino acids; NKD, amino terminus plus kinase domain (residues 1-381); KD, kinase
domain alone (residues 111-381). B, Western blot analysis. Lysates from Cos7 cells expressing wild type or truncated forms of Ack1 were probed
with anti- phospho Ack1 (pY284), anti-HA, and anti-phosphotyrosine antibodies as indicated. The figure is representative of five experiments. C,
densitometry readings were taken from all five experiments and the average was plotted in a bar graph. Error bars indicate standard error.
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Page 2 of 11play a role in the regulation of EGFR stability and vesi-
cle dynamics.
SAM (sterile-alpha motif) domains are modular domains
of ~70 amino acids that were originally identified and
named due to their essential role in sexual differentiation
in yeasts. In spite of their common five-helical structure,
SAM domains do not exhibit significant sequence homol-
ogy [22]. This sequence diversity reflects a large diversity
of function. SAM domains have been found in nearly 1000
proteins that include a diverse array of signaling molecules
such as the transcriptional repressors TEL [23] and Poly-
comb [24], diacyglycerol kinase δ1( D G K δ1) [25], and Eph
receptor tyrosine kinases [26,27].
Structural studies of the SAM domains from the EphA4
r e c e p t o r[ 2 6 ]a n dE p h B 2r e c e p t o r[ 2 7 ]s h o w e dt h a tt h e
helical arrangement creates two interfaces, suggesting a
mechanism for SAM domain dimerization. These inter-
faces are composed of two complementary surfaces that
associate mainly by hydrophobic interactions. Similar
interfaces have been identified in TEL, Polycomb and
DGKδ1, and these SAM domains form extended polymers
that have important regulatory roles. In the lipid kinase
DGKδ1, SAM domain-mediated polymerization keeps the
enzyme in an inactive form and localized to cytoplasmic
vesicles. Upon EGF stimulation, DGKδ1 is recruited to the
plasma membrane, where its substrate is located [25]. The
SAM domain of the transcriptional repressors Polyhomeo-
tic [24] and TEL [23] form helical polymeric filaments,
suggesting a mechanism by which transcriptional repres-
sor complexes might spread along the chromosome.
The amino-terminal 85 residues of Ack1 contain SAM
domain-like sequences that are conserved across species
[1]. Fusion of the Ack1 SAM domain sequence to GFP
resulted in localization at the plasma membrane [1].
Deletion of the SAM domain from full-length Ack1
reduced the level of autophosphorylation in HeLa cells,
suggesting the involvement of the N-terminus in enzyme
regulation [1]. Here, we explore the role of the N-term-
inal domain in Ack1 localization and regulation. Our
data suggest that the SAM domain promotes Ack1
dimerization at the plasma membrane to allow intermo-
lecular autophosphorylation, analogous to the role of the
transmembrane domains of receptor tyrosine kinases.
Results
Analysis of Ack1 autophosphorylation by Western
blotting
To test for the importance of the amino-terminal SAM
domain in Ack1 regulation, we created the deletion and
truncation constructs that are shown in Figure 1A. In
the construct ΔNt, the first 110 amino acid residues
were deleted. NKD corresponds to the first 381 residues
of Ack1 including the SAM domain and the kinase
domain, and KD is the kinase domain alone.
We expressed these constructs in Cos7 cells and ana-
lyzed their activities in whole cell lysates by probing for
phosphorylation of Y284. We previously identified Y284,
which lies in the activation loop of Ack1, as the major
autophosphorylation site [8]. We confirmed that Y284 is
the major site in Cos7 cells, and that it represents a site
of autophosphorylation rather than a site for another
kinase (Additional file 1, Figure S1). Phosphorylated
Ack1 was detected in the lanes corresponding to NKD
and WT, but the lanes corresponding to KD and ΔNt
did not show any detectable signal for pY284-Ack1
(Figure 1B, top panel). Thus, the level of Ack1 autopho-
sphorylation was drastically reduced by the deletion of
the SAM domain both in the context of the full-length
protein (i.e., WT vs. ΔNt) and of the shorter constructs
(NKD vs. KD). The membrane was reprobed with anti-
HA antibody to determine total levels of the proteins in
the blot (Figure 1B, middle panel). Additional examples
are provided in Additional file 2, Figure S2. The ratio of
pY284-Ack1 signal to total Ack1 signal for several blots
is quantified in Figure 1C. These results suggest that the
SAM domain plays an important role in the regulation
of Ack1 by promoting its autophosphorylation.
We also analyzed the overall phosphotyrosine content
of cells expressing the different Ack1 constructs (Figure
1B, bottom panel). Expression of full-length Ack1
resulted in the tyrosine phosphorylation of numerous cel-
lular proteins, while fewer proteins were phosphorylated
in ΔNt-expressing cells. For both full-length Ack1 and
ΔNt, a band was present that co-migrated with the phos-
phorylated Ack1 protein, although the band was weaker
for ΔNt. No signal was observed for ΔNt in the pY284
blot, but this construct contains other previously identi-
fied phosphorylation sites (Y826, Y857) that may account
f o rt h es i g n a li nt h ep T y rb l o t[ 2 8 , 2 9 ] .E x p r e s s i o no ft h e
NKD construct did not produce any drastic change in
the pattern of phosphotyrosine-containing proteins as
compared to untransfected Cos7 cells, but a tyrosine
phosphorylated band migrating at the position of NKD
was detected. In contrast, expression of the isolated
kinase domain (KD) did not stimulate phosphorylation of
cellular proteins compared to untransfected control cells,
and no evidence for autophosphorylation was detected.
This is consistent with the data in the pY284 blot, since
this residue is probably the only one available for phos-
phorylation in KD and NKD. These data suggest that
Ack1 N-terminus is important for its activation.
The deletion of Ack1 N-terminus affects subcellular
localization
As reported earlier [30,31], WT Ack1 was localized to
the cytoplasm in amorphous intracellular structures
(Figure 2). ΔNT was present in similar large intracellular
structures (Figure 2). By contrast, NKD was mostly
Prieto-Echagüe et al. BMC Biochemistry 2010, 11:42
http://www.biomedcentral.com/1471-2091/11/42
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kinase domain (KD) showed a diffuse cytosolic localiza-
tion. The difference between NKD and KD localization
patterns was consistent with the reported ability of the
SAM domain to direct Ack1 to the plasma membrane
[1]. The intracellular localization of WT Ack1 and ΔNT
suggested that other regions of the protein may also
contain targeting information, consistent with the
observation that the C-terminus of Ack1 interacts with
a number of proteins.
Analysis of Ack1 autophosphorylation by quantitative
immunofluorescence
Next, we tested whether the various forms of Ack1 were
active in all cellular sites. We studied the subcellular
localization of the autophosphorylated, activated forms
Figure 2 Localization of Ack1 proteins. Cos7 cells co-expressing wild-type or mutant HA-tagged Ack1 along with a membrane targeted form
of GFP (PM-GFP) [40] were prepared for immunostaining and confocal microscopy as described in Materials and Methods. Ack1 proteins were
detected with anti-HA antibodies. Anti-HA; left panels; PM-GFP, middle panels; merged images, right panels. Scale bar: 10 microns.
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sis using anti-pY284 Ack1 antibody. In the cases where
it was detected, the signal for pY284 Ack1 colocalized
exactly with the distribution of total Ack1 (Figure 3A).
To determine the relative activities of the constructs,
we quantitated anti-pY284 staining (for autophosphory-
lated Ack1) and anti-HA staining (for total Ack1) (Fig-
ures 3B and 3C). The ratios of fluorescence intensities
(pY284/HA) were normalized to the value correspond-
ing to wild type (WT = 100). Figure 3B shows results
from a representative experiment, while 3C shows the
merged data from three experiments. Consistent with
the Western blotting results, the level of autophosphory-
lation was significantly decreased by the deletion of the
N-terminus, both in the context of the full length and
the minimal construct. The construct ΔNt showed a
Figure 3 Quantitative immunofluorescence analysis. A, Cos7 cells expressing wild type or truncated forms of Ack1 were prepared for
immunofluorescence using anti-phospho-Ack1 (pY284) and anti-HA antibodies. Top row: HA staining; middle row: pY284 staining; bottom row:
merged images. The images in panel A were taken from the set used for quantitation and statistics in panels B and C. B, Immunofluorescence
(anti-pY284 and anti-HA) was measured in three separate experiments (30 cells per experiment). The ratio of pY284Ack1/HA in each cell was
calculated and normalized with respect to WT Ack1. Acquisition parameters were the same for all cells, and images shown as well as those used
for quantitation were not further processed. A scatter plot for one representative experiment, with a line at the mean is shown. C, Bar graph
showing the combined data of the three experiments. The data were compared using a one-way ANOVA test (P < 0.0001), followed by a
Tukey’s test of honest significant differences. All groups were significantly different from each other; P < 0.001 for all pairings, with the exception
of KD vs. K158R (P < 0.01). Errors bars indicate standard error.
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wild type, while the isolatedk i n a s ed o m a i n( K D )h a da
~9-fold decrease in autophosphorylation compared to
NKD. The autophosphorylation level of KD was not sig-
nificantly different from the negative control (K158R, a
kinase dead Ack1 mutant).
Concentration-dependent activity of the purified Ack1
kinase domain
A possible explanation for the negligible autophosphory-
lation of the KD construct (Figures 1, 3) is that the iso-
lated kinase domain might be inactive. Several tyrosine
kinase catalytic domains (e.g., Csk, Fes) require the pre-
sence of accessory domains for activity [32,33]. To test
this possibility, we introduced the Ack1 kinase domain
into a recombinant baculovirus, expressed the protein in
insect cells, and purified it to homogeneity. We tested
the catalytic activity of Ack1 kinase domain by carrying
out kinetic experiments using varying concentrations of
a peptide substrate derived from the Tyr256 sequence of
WASP (KVIYDFEKKKG). As shown in Figure 4A, the
purified kinase domain was active towards the peptide.
Experiments with varying ATP concentrations yielded a
KM(ATP) value of 107 μM (data not shown). Thus,
although the kinase domain expressed in cells is inac-
tive, the isolated kinase domain has intrinsic tyrosine
kinase activity. We hypothesized that the observed activ-
ity in vitro may be a function of the increased protein
concentration under these conditions. The SAM
domains in other proteins mediate polymerization pro-
cesses that regulate activity [22], and the SAM domain
o fA c k 1a c t sa sam e m b r a n e - t argeting signal (Figure 2
and ref. [1]). In full-length Ack1, the SAM domain may
increase the local concentration by causing dimerization
or multimerization at the sites where it is recruited.
Kinases that dimerize and transphosphorylate show
concentration-dependent activity. In order to test the
effect of Ack1 concentration on autophosphorylation,
we first dephosphorylated the His6-tagged enzyme puri-
fied from Sf9 cells using the Yersinia phosphatase Yop.
Next, we used lipid vesicles to control the local concen-
tration of Ack1 kinase domain. Dephosphorylated Ack1
was incubated with ATP in the presence of small unila-
mellar vesicles containing different mole fractions of a
lipid with a Ni-NTA head group (DOGS-NTA-Ni). This
method was used previously to demonstrate the activa-
tion of EGFR by formation of an asymmetric dimer [34].
Thus, in these experiments, we mimicked the dimeriza-
tion function of the SAM domain by using the hexahis-
tidine tag to control the local concentrations of the
isolated kinase domain. The concentration of enzyme
was kept constant, and the concentration of Ni-NTA
was kept constant (by varying the total vesicle concen-
tration) to ensure that any observed effects were due to
Figure 4 Activity of purified Ack1 kinase domain. A, purified
Ack1 kinase domain is active in vitro. The catalytic activity of Ack1
kinase domain was measured towards a WASP-derived peptide at
different enzyme concentrations. The figure is representative of
three experiments. B, increasing local concentrations of purified
Ack1 kinase domain at the surface of lipid vesicles stimulates
autophosphorylation. The purified dephosphorylated Ack1 kinase
domain was incubated in the presence or absence of ATP and in
the presence of lipid vesicles containing different mole ratios of
DOGS NTA-Ni. After the reaction, equal amounts of Ack1 kinase
domain were separated by SDS-PAGE and analyzed by Western
blotting using anti- phospho-Ack1 (pY284) and anti His6 antibodies.
In these experiments, the enzyme concentration was 142 nM and
the Ni-NTA was kept constant at 58.5 μM. In order to keep the Ni-
NTA concentration constant, the amount of total lipids was varied
inversely with the mole % of Ni-NTA in the vesicles. For 0% and 2%
Ni-NTA, the total lipid concentration was 3.3 mM and for 5% Ni-NTA
the lipid concentration was 1.3 mM. No ATP/No ves: reaction in the
absence of vesicles and ATP. No ves: reaction in the absence of
vesicles. The figure is representative of three experiments. C,
quantitation of the western blots described in B. Densitometry
readings were used to calculate the ratios of phosphorylated Ack1
(pY284 blot) to Ack1 (His6 blot). Error bars indicate standard error.
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the purified kinase domain to vesicles caused a signifi-
cant increase in autophosphorylation, as judged by anti-
pY284 Western blotting (Figure 4B, C). The stimulation
of autophosphorylation by DOGS-NTA-Ni was dose-
dependent, as vesicles with 5 mole % DOGS-NTA-Ni
produced a further increase over vesicles with 2 mole %
DOGS-NTA-Ni. Vesicles that contained no Ni-NTA did
not produce any increase in autophosphorylation com-
pared to the activity in the absence of vesicles, indicat-
ing that that the observed effect was not due to any
unspecific interaction between lipids and proteins (Fig-
ure 4B, C).
The vesicles were also used to analyze the catalytic
activity of purified Ack1 kinase domain towards a pep-
tide substrate in a continuous spectrophotometric assay
(Figure 5). The catalytic activity of the enzyme in the
presence of vesicles containing 5 mole % DOGS-NTA-
Ni was 2-fold higher than with vesicles containing no
Ni-NTA, or than solution reactions (i.e., in the absence
of vesicles). We confirmed that the effect was due to
binding between the His6-Ack1 kinase domain and
DOGS-NTA-Ni by performing the assay in the presence
of 500 mM imidazole; under these conditions the Ack1
activity was comparable to the activity observed in the
absence of vesicles or in solution. Taken together, the
data show that artificially increasing the local concentra-
tion of the isolated kinase domain increases autopho-
sphorylation and catalytic activity.
Ack1 self associates in cells
We investigated the capacity of Ack1 constructs to self-
associate in cells. Cos 7 cells were transfected with
Flag-tagged full length Ack1 alone or together with HA-
tagged NKD or KD. Flag-Ack1 was immunoprecipitated
from the cell lysates using anti-Flag antibody, processed
for SDS-PAGE and transferred to PVDF membranes.
Blots were probed for the presence of co-immunopreci-
pitated HA-tagged proteins. The densitometry readings
corresponding to Flag-tagged Ack1 and to HA-tagged
Ack1 in the immunocomplexes were used to calculate
the ratio HA-Ack1/Flag-Ack1. We found that HA-NKD
coimmunoprecipitated with Flag Ack1 3-fold more
strongly than HA-KD (Figure 6). Thus, although there is
residual self-association between the kinase domain and
full-length Ack1, these data suggest that the N-terminal
region strengthens the association.
Discussion
SAM domains are a diverse group of protein-protein
interaction motifs that frequently mediate homo- or het-
ero- dimerization and oligomerization. In several
enzymes, SAM domains regulate activity by localized
polymerization at the membrane or in the nucleus. In
Figure 6 Ack1 self-associates in cells. Cos7 cells were transfected
with Flag-tagged wild type Ack1 alone or together with HA-tagged
Ack1 NKD or KD. Ack1 was immunoprecipitated from cell lysates
with anti-Flag antibodies, and the immunocomplexes were analyzed
by Western blotting with anti-Flag and anti-HA antibodies.
Densitometry readings of the immunoprecipitated proteins (top
panels) were used to calculate the ratios of immunoprecipitated
HA-Ack1 to immunoprecipitated Flag-Ack1. The HA:Flag ratio for KD
was arbitrarily set to 1. Samples of whole cell lysates were analyzed
for the presence of the transfected proteins (bottom panels). The
figure is representative of three experiments.
Figure 5 Increasing local concentrations of purified Ack1
kinase domain at the surface of lipid vesicles increases
catalytic activity. The catalytic activity of Ack1 kinase domain
towards a peptide was measured as in Figure 4. The activities of
purified Ack1 kinase domain were measured in solution (no ves) or
with vesicles containing 0 or 5 mole % of DOGS-NTA-Ni. In one
experiment (5% + Im), the reaction was carried out in the presence
of 500 mM imidazole. The enzyme concentration was 250-500 nM,
peptide substrate was used at 1 mM, and the Ni-NTA concentration
was kept constant at 30 μM. The figure shows the average results of
nine experiments performed in triplicate. Errors bars indicate
standard error.
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required for autophosphorylation. Our data suggest that
the N-terminus of Ack1 mediates self-association, and
that the increased local concentrations result in
increased autophosphorylation and kinase activity.
To study the role of the Ack1 N-terminus in autopho-
sphorylation, we deleted the first 110 amino acids of the
polypeptide (ΔNt) and we compared it to the full-length
protein (WT). In addition, we created a minimal con-
struct that contains only the N-terminus and the kinase
domain (NKD) and we compared it to the isolated
kinase domain (KD). Since Ack1 is a large protein that
contains several different regions, some of whose roles
are not completely understood, this simplified system
proved to be useful to dissect the role of the N-terminus
in Ack1 activation and intracellular localization.
The deletion of the Ack1 N-terminus produced a sig-
nificant decrease in Ack1 autophosphorylation in cells.
Similar trends were observed by two different methods,
although the Western blot quantitation method appears
to have a broader dynamic range than the quantitative
immunofluorescence. Autophosphorylation of ΔNt was
15-fold lower than WT Ack1 by Western blotting (Fig-
ure 1) and 2-fold lower by immunofluorescence (Figure
3). The effect on the minimal NKD construct was more
pronounced: autophosphorylation of KD was 27-fold
lower than NKD by Western blotting and 9-fold lower
by immunofluorescence. In the immunofluorescence
assays (Figure 3), autophosphorylation of KD was signifi-
cantly lower than ΔNt. A possible explanation for this
difference is that other regions of Ack1, in addition to
the N-terminus, may mediate interactions or provide
inputs that result in increased autophosphorylation.
Consistent with published data [1], we observed that
Ack1 N-terminus is a membrane-targeting domain (Fig-
ures 2 and 3). The minimal constructs NKD and KD
show very distinct intracellular localizations: NKD is
clearly localized at the plasma membrane and phos-
phorylated, while KD is diffuse and cytosolic, and
unphosphorylated at Y284 (Figures 2 and 3). The situa-
tion is more complex in the cases of WT and ΔNt.
They both show a punctate distribution that is not iden-
tical to either NKD or KD. This suggests that the locali-
zation of full-length Ack1 results from the cumulative
effect of interactions mediated by the SAM domain and
other regions of the protein. It is likely that interactions
between full-length Ack1 and other proteins including
clathrin [2], sorting nexin 9 [7], and ubiquitinated EGFR
[4] play a role in determining subcellular localization.
In the context of full-length Ack1, the primary func-
tion of the SAM domain may be to promote enzyme
activation. We used an in vitro system to explicitly test
the hypothesis that self-association is an activation
mechanism for Ack1. We found that Ack1 kinase
domain attached to vesicles showed a concentration-
dependent increase in autophosphorylation and in
phosphorylation of an exogenous substrate (Figures 4
and 5). FLAG-Ack1 co-immunoprecipitated more
weakly with HA-KD than with HA-NKD, suggesting
that the N-terminus promotes Ack1 homodimerization
(Figure 6). These results suggest that increasing the
local concentration of Ack1 catalytic domain by SAM
domain-mediated dimerization is potentially a mechan-
ism for enzyme activation.
Counterbalancing mechanisms presumably exist to
reverse the SAM domain-mediated activation of Ack1.
Although these mechanisms are undefined at present,
the domain arrangement of Ack1 is complex, and it is
likely that other regions of the polypeptide are involved
in Ack1 downregulation. We have shown that the Mig6-
homology region (MHR) located at the C-terminus of
Ack1 is involved in an intramolecular autoinhibitory
interaction [31]. The MHR is also capable of binding to
EGFR kinase domain in vitro (V.P.E., W.T.M.; unpub-
lished observations) and in cell lysates [4]. This Ack1-
EGFR interaction could potentially be involved in the
dynamic regulation of Ack1 activity. Growth factor
treatment of cells promotes phosphorylation of the
Ack1 C-terminus [29,30], which could potentially desta-
bilize autoinhibitory interactions and unmask the SAM
domain for membrane recruitment and Ack1 activation.
Conclusions
Our data suggest that: (1) The N-terminal SAM domain
of Ack1 is required for full Ack1 autophosphorylation
and kinase activity; (2) The SAM domain has the poten-
tial to drive Ack1 to the plasma membrane, although in
the context of full-length Ack1 other protein-protein
interactions make important contributions; (3) Increas-
ing the local concentration of Ack1 stimulates in vitro
kinase activity; and (4) Ack1 forms dimers (or higher-
order multimers) in cells.
Methods
Reagents and antibodies
Bovine serum albumin, leupeptin, aprotinin, PMSF,
sodium vanadate, sodium fluoride, pyruvate kinase/lac-
tate dehydrogenase enzymes, and EZview red anti-FLAG
M2 affinity gel were obtained from Sigma. Egg PC and
DOGS-NTA-Ni were from Avanti Polar lipids, Inc.
Trypsin-EDTA solution was from Mediatech Inc. Pri-
mary antibodies were obtained from the following com-
panies: rabbit polyclonal anti-Ack1, rabbit polyclonal
anti-pY284 Ack1 and mouse monoclonal anti-phospho-
tyrosine clone 4G10 were from Millipore, mouse mono-
clonal anti-His6 was from Covance, rat monoclonal
anti-HA high affinity clone 3F10 was from Roche. The
primary antibodies used for immunofluorescence were
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Materials and rabbit anti-HA tag antibodies from
Sigma-Aldrich. The secondary antibodies were horserad-
ish peroxidase linked secondary antibodies (donkey anti-
rabbit IgG and sheep anti- mouse IgG horseradish) from
GE Healthcare. Alexa Fluor (AF)-594-transferrin and
AF-488- and AF-594-goat anti-mouse and goat anti-
rabbit IgG secondary antibodies were from Molecular
Probes, Invitrogen. The plasmid PM-GFP, encoding the
NH2-terminal 10-amino acid acylation sequence of Lyn
linked to GFP, was provided by Pietro De Camilli
(Howard Hughes Medical Institute, Yale University
School of Medicine).
Cell culture
Mammalian cells were maintained in DMEM (Cellgro,
Mediatech, Inc) supplemented with 10% fetal bovine
serum (Sigma) and 1000 IU/ml penicillin, 1000 IU/ml
streptomycin, 25 ng/ml amphotericin B (Cellgro, Media-
tech, Inc). The Sf9 insect cells were maintained in Sf-
900 medium (Gibco) supplemented with 5% fetal bovine
serum and 1000 IU/ml streptomycin, 25 ng/ml ampho-
tericin B (Cellgro, Mediatech, Inc).
Cloning and site-directed mutagenesis
Plasmid pXJ-HA-Ack1 encoding full length Ack1 was a
kind gift from Dr. Edward Manser (Institute of Molecu-
lar and Cell Biology, Singapore). A plasmid encoding
EGFP-clathrin light chain A in pEGFP-C3 [35] was the
gift of Lois Greene (National Heart, Lung, and Blood
Institute, National Institutes of Health, Bethesda, MD).
The plasmid pXJ-HA-Ack1 was modified to produce the
different constructs used in this study. The ΔNt con-
struct was generated by PCR amplification of DNA
encoding residues 330-1085 using primers that con-
tained the restriction sites BamHI and HindIII. To gen-
erate the NKD construct, a termination signal (TGA)
was inserted after codon 385 by site-directed mutagen-
esis. The KD construct was made by subcloning the
region encoding Ack1 kinase domain (residues 110 to
385) into pXJ-HA. To produce FLAG-tagged Ack1, the
coding region region for full length Ack1 was subcloned
from pXJ-HA into the plasmid p(3X)FLAG CMV 7.1
(Sigma) using the restriction sites BamHI and HindIII.
Cell transfection and Western blotting
For Western blotting, Cos7 cells (from American Type
Culture Collection (ATCC), Manassas, VA) (3 × 10
6)
were plated in 15 cm diameter dishes. After 24 hours,
the cells were transfected using 30-60 μgD N Aw i t h
TransIT reagent (Mirus) at a ratio of 2 μlT r a n s I Tp e r
μg of DNA. After 24 hours, the reagent was removed,
and the cells were cultured for an additional 24 hours.
The cells were harvested, washed twice in PBS, and
lysed using RIPA buffer (50 mM Tris-HCl pH 7.4, 150
mM NaCl, 5 mM EDTA, 1% sodium deoxycholate, 1%
Nonidet P-40) supplemented with the protease inhibi-
tors leupeptin (10 μg/ml), aprotinin (10 μg/ml), PMSF
(200 μM) and the phosphatase inhibitors Na3VO4 (0.2
mM) and NaF (10 mM). Lysates (30 μg) were separated
by 10% SDS-PAGE, transferred to PVDF membrane,
and probed with appropriate antibodies.
For immunofluorescence, the transfections were car-
ried out as follows: Cos7 cells were maintained in
Dulbecco’s modified Eagle’s medium with 10% iron-sup-
plemented calf serum (JRH, Lenexa, KS) and penicillin/
streptomycin. Transient transfection of cells seeded on
acid-washed glass coverslips was performed using fully-
deacylated polyethylenimine (PEI) reagent, prepared
from 200 kDa poly(2-ethyl-2-oxazoline) (Sigma-Aldrich,
St. Louis, MO) as described [36]. Transfection mixtures
contained 2 μgD N Aa n d1 2μl PEI reagent per 35 mm
dish. Cells were examined one day after transfection.
Fluorescence microscopy
Cells grown on glass coverslips were fixed in phosphate-
buffered saline (PBS; 150 mM NaCl, 20 mM phosphate
buffer, pH 7.4) containing 3% paraformaldehyde for 30
minutes, permeabilized with PBS containing 0.5% Triton
X-100 and blocked with PBS containing 3% bovine
serum albumin (BSA) and 10 mM glycine for 1 hour.
Cells were incubated with primary antibodies for 1 hour
and secondary antibodies for 30 minutes, both in PBS
with 3% BSA and 10 mM glycine. Cells were photo-
graphed and images were captured using a Zeiss LSM
510 META NLO laser scanning confocal microscope
using a 100x oil immersion objective. For quantification,
a region of interest (ROI) was drawn around individual
cells, and the histogram macro on the Zeiss LSM soft-
ware was used to quantify the mean fluorescence inten-
sity of each cell in both red and green channels, and the
ratio of anti-pY284 to anti-HA staining in each cell was
calculated. Acquisition parameters were the same for all
cells, and images shown as well as those used for quan-
titation were not further processed. 30 cells expressing
each construct were analyzed in each of three separate
experiments.
Protein expression and purification
A recombinant baculovirus encoding the Ack1 kinase
domain (residues 110-385; Prieto-Echagüe et al. [31])
was used to infect 400 ml of Sf9 cells at 2 × 10
6 cell/ml
with MOI~5. The infected cells were collected after 48
hours and lysed in a French pressure cell in 20 mM
Tris-HCl buffer (pH 8.0), containing 5 mM 2-mercap-
toethanol, 10 μg/ml leupeptin, 10 μg/ml aprotinin,
1 mM PMSF, and 1 mM Na3VO4. The cell homogenates
were cleared by centrifugation at 40,000 g for 30 min,
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NTA column (Qiagen). First, the column was washed
with 120 ml of 20 mM Tris-HCl buffer (pH 8.0) con-
taining 2 mM imidazole, 0.5 M NaCl, 10% glycerol, 5
mM 2-mercaptoethanol, 2 mM Na3VO4.T h es e c o n d
w a s hw a sw i t h4 0m lo f2 0m MT r i s - H C lb u f f e r( p H
8.0) containing 1 M NaCl and a third wash was carried
out with 40 ml of 20 mM Tris-HCl buffer (pH 8.0). Buf-
fer containing 20 mM Tris-HCl (pH 8.0),100 mM imi-
dazole, 5 mM 2-mercaptoethanol and 10% glycerol was
used to elute the His6-tagged proteins. The fractions
containing Ack1 kinase domain were pooled, supple-
mented with 20% glycerol, and stored at -80°C.
Co-immunoprecipitation studies
Cos 7 cells were transfected with full length FLAG-Ack1
alone or cotransfected with HA-tagged Ack1 (NKD or
KD) and lysed after 48 hours using RIPA buffer, as
described for the Western blotting experiments. Cell
lysates (450-750 μg) were incubated overnight at 4°C
with 40 μl of FLAG M2 affinity gel. The immunocom-
plexes were washed 5 times with 1 ml RIPA buffer,
eluted from the beads using 35 μl of 2X Laemmli buffer
and separated by SDS-PAGE. The proteins were trans-
ferred to PVDF membranes and analyzed by immuno-
blotting using anti-HA antibody and anti-FLAG
antibody.
Preparation of small unilamellar vesicles
The lipids egg PC and DOGS-NTA-Ni were mixed in dif-
ferent molar ratios in glass tubes. The chloroform from
500 μl of the mixture was evaporated under an argon
stream to form a thin film, and the lipids were dried
under vacuum for at least one hour. The dried lipids
were resuspended to create large multilamellar vesicles
by the addition of 500 μl of rehydration buffer (20 mM
Tris pH 7.4 and 10 mM MgCl2) followed by 4 cycles of
freezing, thawing and 30 seconds vigorous vortexing.
Small unilamellar vesicles were produced by passing the
large multilamellar vesicles through a polycarbonate filter
(pore size: 100 nm) 10 times, using a mini-extruder
(Avanti Polar lipids, Inc). The vesicles were used for in
vitro assays on the same day of preparation.
In vitro autophosphorylation reactions
Purified His6-Ack1 kinase domain was dephosphorylated
by incubating 10 μg of protein with immobilized GST-
tagged Yersinia phosphatase (Yop) for 30 minutes at
room temperature. For the autophosphorylation reac-
tions on vesicles, dephosphorylated Ack1 (500 ng) was
incubated with kinase buffer (100 mM Tris-HCl pH 7.4,
10 mM MgCl2, 25 mM vanadate, and 500 mM ATP) in
the presence of vesicles containing different mole frac-
tions of DOGS-NTA-Ni (0%, 2% or 5%). Reactions
proceeded for 15 minutes at room temperature and
were stopped by adding Laemmli buffer and boiling for
5 minutes. Samples were analyzed by SDS-PAGE. The
proteins were transferred to PVDF membranes and ana-
lyzed by immunoblotting using anti-phosphoAck1
(Y184) and anti-His6 antibodies.
In vitro kinase assay in solution and with vesicles
The catalytic activity of the purified Ack1 kinase domain
towards a peptide substrate was measured using a con-
tinuous spectrophotometric assay [37,38]. Reactions
were performed at 30°C in a final volume of 50 μl. The
substrate used was a peptide containing the tyrosine
phosphorylation site in the protein WASP that is phos-
phorylated by Ack1 [39]. The reactions contained
1 0 0m MT r i sp H7 . 4 ,1 0m MM g C l 2,2m MA T P ,
1.5 mM phosphoenolpyruvate (PEP), 90 units/ml pyru-
vate kinase, 109 units/ml lactate dehydrogenase, and
1.2 mg/ml NADH. For determination of kinetic con-
stants, the peptide substrate concentration was varied
from 5 μM to 5 mM; for experiments with vesicles, the
peptide concentration was 625 μM.
Additional material
Additional file 1: Fig S1. Supplementary data showing tyrosine 284 is
the major autophosphorylation site.
Additional file 2: Fig S2. Supplementary data showing N-terminus is
required for Ack1 autophosphorylation.
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